Polypeptide production in animal cell culture
Abstract
A method-of producing a polypeptide in fed batch cell culture is provided which involves an initial cell growth phase and a distinct production phase. In the initial growth stage, animal cells having nucleic acid encoding the polypeptide are cultured at a starting osmolality of about 280-330 mOsm in the presence of a concentration of glucose controlled throughout the culturing to be within a range between about 0.01 and 1 g/L. This is followed by a production phase, where the cultured animal cells of the growth phase are inoculated at a cell seed density of at least 1.0×10 6 cells/mL and the cells are cultured at a starting osmolarity of about 400-600 mOsm in the presence of a concentration of glucose controlled throughout the culturing to be within a range between about 0.01 and 1 g/L. Preferably, the glutamine concentration in the cell culture medium is simultaneously controlled in order to curtail production of lactic acid and ammonia which result from unnecessarily high glutamine concentrations. During the growth phase, production of potentially detrimental metabolic waste products, such as lactic acid, is controlled thereby curtailing the increase of osmolality due to accumulation and neutralization of waste products. Thus, the cell growth can be improved. In the production phase, the cell culture conditions are modified in order to arrest or reduce cell growth and thereby direct nutrient utilization toward production, as opposed to cell growth. Overall, it is intended that the method results in an improvement in specific productivity, reduction in production run times and/or an increase in final product concentration.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of growing animal cells in fed batch cell culture comprising the steps of culturing the cells at a starting osmolality of about 280-330 mOsm and controlling the glucose concentration in the cell culture to be between about 0.01 and 1 g/L throughout the culturing.
2 . A method of producing a polypeptide by animal cells comprising nucleic acid encoding the polypeptide in fed batch cell culture, comprising the steps of culturing the cells at a starting osmolality of about 400-600 mOsm and controlling the glucose concentration in the cell culture to be between about 0.01 and 1 g/L throughout the culturing, wherein the starting cell density is at least about 1.0×10 6 cells/mL.
3 . A method of producing a polypeptide in cell culture comprising the steps of:
(a) in an initial growth stage, culturing animal cells comprising nucleic acid encoding the polypeptide at a starting osmolality of about 280-330 mOsm in the presence of a concentration of glucose controlled throughout the culturing to be within a range between about 0.01 and 1 g/L, and (b) in a production phase separate from step (a), inoculating the cultured animal cells of step (a) at a cell seed density of at least about 1.0×10 6 cells/mL; and (c) culturing the animal cells at a starting osmolarity of about 400-600 mOsm in the presence of a concentration of glucose controlled throughout the culturing to be within a range between about 0.01 and 1 g/L, inclusive.
4 . The method of claim 3 wherein the glucose concentration is controlled in a range between about 0.02 and 0.5 g/L for both steps (a) and (c).
5 . The method of claim 4 wherein the glucose concentration is controlled in a range between about 0.05 and 0.2 g/L for both steps (a) and (c).
6 . The method of claim 3 wherein the osmolality is in the range 400-500 mOsm for step (c).
7 . The method of claim 3 wherein the animal cells are cultured in the presence of a concentration of glutamine controlled throughout culturing steps (a) and (c) to be in a range between about 0.2 and 2 mM.
8 . The method of claim 3 wherein the culture medium contains excess amino acids.
9 . The method of claim 8 wherein the amino acids are selected from the group consisting of Asn, Asp, Gly, Ile, Leu, Lys, Met, Ser, Thr, Trp, Tyr and Val.
10 . The method of claim 3 wherein the cells are mammalian cells.
11 . The method of claim 10 wherein the cells are Chinese Hamster Ovary (CHO) cells.
12 . The method of claim 3 wherein the polypeptide is DNase.
13 . The method of claim 12 wherein the osmolality in step (c) is about 400-500 mOsm.
14 . The method of claim 3 wherein the polypeptide is TGF.
15 . The method of claim 14 wherein the osmolality in step (c) is about 400-450 mOsm.
16 . The method of claim 3 wherein step (c) is terminated before the maximum polypeptide titer is obtained.
17 . The method of claim 3 wherein step ,(c) is terminated after 9 days or less.
18 . DNase produced by the process of claim 17 .
19 . TGFβ produced by the process of claim 17.Join the waitlist — get patent alerts
Track US2004048368A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.